Nanotechnology In Cancer Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Application (Cancer Detection, Imaging, Drug Delivery, Radiotherapy, Immunotherapy, Phototherapy)
Report Code: TIPRE00016772 No. of Pages: 150 Category: Medical Device Status: Upcoming
MARKET INTRODUCTION
Nanotechnology offers the means to target chemotherapies directly and selectively to cancerous cells and neoplasms, guide in surgical resection of tumors, and enhance the therapeutic efficacy of radiation-based and other current treatment modalities.
MARKET DYNAMICS
The nanotechnology in cancer treatment market is driving due to rapidly emerging opportunities in the application of nanotechnology in cancer treatment. However, high cost of the technology act as the major barriers.
MARKET SCOPE
The "Nanotechnology in Cancer Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of nanotechnology in cancer treatment market with detailed market segmentation by application. The nanotechnology in cancer treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in nanotechnology in cancer treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The nanotechnology in cancer treatment market is segmented on the basis of application. On the basis of application, the market is segmented into cancer detection, imaging, drug delivery, radiotherapy, immunotherapy and phototherapy.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Nanotechnology in Cancer Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Nanotechnology in Cancer Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Nanotechnology in Cancer Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Nanotechnology in Cancer Treatment market in these regions.
The report covers key developments in the nanotechnology in cancer treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from nanotechnology in cancer treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for nanotechnology in cancer treatment market in the global market. Below mentioned is the list of few companies engaged in the nanotechnology in cancer treatment market.
The report also includes the profiles of key players in nanotechnology in cancer treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Nanotechnology offers the means to target chemotherapies directly and selectively to cancerous cells and neoplasms, guide in surgical resection of tumors, and enhance the therapeutic efficacy of radiation-based and other current treatment modalities.
MARKET DYNAMICS
The nanotechnology in cancer treatment market is driving due to rapidly emerging opportunities in the application of nanotechnology in cancer treatment. However, high cost of the technology act as the major barriers.
MARKET SCOPE
The "Nanotechnology in Cancer Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of nanotechnology in cancer treatment market with detailed market segmentation by application. The nanotechnology in cancer treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in nanotechnology in cancer treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The nanotechnology in cancer treatment market is segmented on the basis of application. On the basis of application, the market is segmented into cancer detection, imaging, drug delivery, radiotherapy, immunotherapy and phototherapy.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Nanotechnology in Cancer Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Nanotechnology in Cancer Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Nanotechnology in Cancer Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Nanotechnology in Cancer Treatment market in these regions.
The report covers key developments in the nanotechnology in cancer treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from nanotechnology in cancer treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for nanotechnology in cancer treatment market in the global market. Below mentioned is the list of few companies engaged in the nanotechnology in cancer treatment market.
The report also includes the profiles of key players in nanotechnology in cancer treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Combimatrix Corporation
- GE Healthcare
- Leadiant Biosciences, Inc.
- Johnson & Johnson
- Mallinckrodt Plc
- Merck & Company Inc.
- Nanosphere Inc.
- Pfizer, Inc.
- Celgene Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nanotechnology In Cancer Treatment Market - By Application
1.3.2 Nanotechnology In Cancer Treatment Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NANOTECHNOLOGY IN CANCER TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NANOTECHNOLOGY IN CANCER TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NANOTECHNOLOGY IN CANCER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. NANOTECHNOLOGY IN CANCER TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NANOTECHNOLOGY IN CANCER TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NANOTECHNOLOGY IN CANCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CANCER DETECTION
7.3.1. Overview
7.3.2. Cancer Detection Market Forecast and Analysis
7.4. IMAGING
7.4.1. Overview
7.4.2. Imaging Market Forecast and Analysis
7.5. DRUG DELIVERY
7.5.1. Overview
7.5.2. Drug Delivery Market Forecast and Analysis
7.6. RADIOTHERAPY
7.6.1. Overview
7.6.2. Radiotherapy Market Forecast and Analysis
7.7. IMMUNOTHERAPY
7.7.1. Overview
7.7.2. Immunotherapy Market Forecast and Analysis
7.8. PHOTOTHERAPY
7.8.1. Overview
7.8.2. Phototherapy Market Forecast and Analysis
8. NANOTECHNOLOGY IN CANCER TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Nanotechnology In Cancer Treatment Market Overview
8.1.2 North America Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.1.3 North America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.1.4 North America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.1.4.1 United States Nanotechnology In Cancer Treatment Market
8.1.4.1.1 United States Nanotechnology In Cancer Treatment Market by Application
8.1.4.2 Canada Nanotechnology In Cancer Treatment Market
8.1.4.2.1 Canada Nanotechnology In Cancer Treatment Market by Application
8.1.4.3 Mexico Nanotechnology In Cancer Treatment Market
8.1.4.3.1 Mexico Nanotechnology In Cancer Treatment Market by Application
8.2. EUROPE
8.2.1 Europe Nanotechnology In Cancer Treatment Market Overview
8.2.2 Europe Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.2.3 Europe Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.2.4 Europe Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Nanotechnology In Cancer Treatment Market
8.2.4.1.1 Germany Nanotechnology In Cancer Treatment Market by Application
8.2.4.2 France Nanotechnology In Cancer Treatment Market
8.2.4.2.1 France Nanotechnology In Cancer Treatment Market by Application
8.2.4.3 Italy Nanotechnology In Cancer Treatment Market
8.2.4.3.1 Italy Nanotechnology In Cancer Treatment Market by Application
8.2.4.4 Spain Nanotechnology In Cancer Treatment Market
8.2.4.4.1 Spain Nanotechnology In Cancer Treatment Market by Application
8.2.4.5 United Kingdom Nanotechnology In Cancer Treatment Market
8.2.4.5.1 United Kingdom Nanotechnology In Cancer Treatment Market by Application
8.2.4.6 Rest of Europe Nanotechnology In Cancer Treatment Market
8.2.4.6.1 Rest of Europe Nanotechnology In Cancer Treatment Market by Application
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Nanotechnology In Cancer Treatment Market Overview
8.3.2 Asia-Pacific Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.3.3 Asia-Pacific Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.3.4 Asia-Pacific Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Nanotechnology In Cancer Treatment Market
8.3.4.1.1 Australia Nanotechnology In Cancer Treatment Market by Application
8.3.4.2 China Nanotechnology In Cancer Treatment Market
8.3.4.2.1 China Nanotechnology In Cancer Treatment Market by Application
8.3.4.3 India Nanotechnology In Cancer Treatment Market
8.3.4.3.1 India Nanotechnology In Cancer Treatment Market by Application
8.3.4.4 Japan Nanotechnology In Cancer Treatment Market
8.3.4.4.1 Japan Nanotechnology In Cancer Treatment Market by Application
8.3.4.5 South Korea Nanotechnology In Cancer Treatment Market
8.3.4.5.1 South Korea Nanotechnology In Cancer Treatment Market by Application
8.3.4.6 Rest of Asia-Pacific Nanotechnology In Cancer Treatment Market
8.3.4.6.1 Rest of Asia-Pacific Nanotechnology In Cancer Treatment Market by Application
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Nanotechnology In Cancer Treatment Market Overview
8.4.2 Middle East and Africa Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.4.3 Middle East and Africa Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.4.4 Middle East and Africa Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Nanotechnology In Cancer Treatment Market
8.4.4.1.1 South Africa Nanotechnology In Cancer Treatment Market by Application
8.4.4.2 Saudi Arabia Nanotechnology In Cancer Treatment Market
8.4.4.2.1 Saudi Arabia Nanotechnology In Cancer Treatment Market by Application
8.4.4.3 U.A.E Nanotechnology In Cancer Treatment Market
8.4.4.3.1 U.A.E Nanotechnology In Cancer Treatment Market by Application
8.4.4.4 Rest of Middle East and Africa Nanotechnology In Cancer Treatment Market
8.4.4.4.1 Rest of Middle East and Africa Nanotechnology In Cancer Treatment Market by Application
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Nanotechnology In Cancer Treatment Market Overview
8.5.2 South and Central America Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.5.3 South and Central America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.5.4 South and Central America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Nanotechnology In Cancer Treatment Market
8.5.4.1.1 Brazil Nanotechnology In Cancer Treatment Market by Application
8.5.4.2 Argentina Nanotechnology In Cancer Treatment Market
8.5.4.2.1 Argentina Nanotechnology In Cancer Treatment Market by Application
8.5.4.3 Rest of South and Central America Nanotechnology In Cancer Treatment Market
8.5.4.3.1 Rest of South and Central America Nanotechnology In Cancer Treatment Market by Application
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NANOTECHNOLOGY IN CANCER TREATMENT MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NANOTECHNOLOGY IN CANCER TREATMENT MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. COMBIMATRIX CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GE HEALTHCARE
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LEADIANT BIOSCIENCES, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JOHNSON AND JOHNSON
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MALLINCKRODT PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND COMPANY INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NANOSPHERE INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CELGENE CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nanotechnology In Cancer Treatment Market - By Application
1.3.2 Nanotechnology In Cancer Treatment Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NANOTECHNOLOGY IN CANCER TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NANOTECHNOLOGY IN CANCER TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NANOTECHNOLOGY IN CANCER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. NANOTECHNOLOGY IN CANCER TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NANOTECHNOLOGY IN CANCER TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NANOTECHNOLOGY IN CANCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CANCER DETECTION
7.3.1. Overview
7.3.2. Cancer Detection Market Forecast and Analysis
7.4. IMAGING
7.4.1. Overview
7.4.2. Imaging Market Forecast and Analysis
7.5. DRUG DELIVERY
7.5.1. Overview
7.5.2. Drug Delivery Market Forecast and Analysis
7.6. RADIOTHERAPY
7.6.1. Overview
7.6.2. Radiotherapy Market Forecast and Analysis
7.7. IMMUNOTHERAPY
7.7.1. Overview
7.7.2. Immunotherapy Market Forecast and Analysis
7.8. PHOTOTHERAPY
7.8.1. Overview
7.8.2. Phototherapy Market Forecast and Analysis
8. NANOTECHNOLOGY IN CANCER TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Nanotechnology In Cancer Treatment Market Overview
8.1.2 North America Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.1.3 North America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.1.4 North America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.1.4.1 United States Nanotechnology In Cancer Treatment Market
8.1.4.1.1 United States Nanotechnology In Cancer Treatment Market by Application
8.1.4.2 Canada Nanotechnology In Cancer Treatment Market
8.1.4.2.1 Canada Nanotechnology In Cancer Treatment Market by Application
8.1.4.3 Mexico Nanotechnology In Cancer Treatment Market
8.1.4.3.1 Mexico Nanotechnology In Cancer Treatment Market by Application
8.2. EUROPE
8.2.1 Europe Nanotechnology In Cancer Treatment Market Overview
8.2.2 Europe Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.2.3 Europe Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.2.4 Europe Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Nanotechnology In Cancer Treatment Market
8.2.4.1.1 Germany Nanotechnology In Cancer Treatment Market by Application
8.2.4.2 France Nanotechnology In Cancer Treatment Market
8.2.4.2.1 France Nanotechnology In Cancer Treatment Market by Application
8.2.4.3 Italy Nanotechnology In Cancer Treatment Market
8.2.4.3.1 Italy Nanotechnology In Cancer Treatment Market by Application
8.2.4.4 Spain Nanotechnology In Cancer Treatment Market
8.2.4.4.1 Spain Nanotechnology In Cancer Treatment Market by Application
8.2.4.5 United Kingdom Nanotechnology In Cancer Treatment Market
8.2.4.5.1 United Kingdom Nanotechnology In Cancer Treatment Market by Application
8.2.4.6 Rest of Europe Nanotechnology In Cancer Treatment Market
8.2.4.6.1 Rest of Europe Nanotechnology In Cancer Treatment Market by Application
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Nanotechnology In Cancer Treatment Market Overview
8.3.2 Asia-Pacific Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.3.3 Asia-Pacific Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.3.4 Asia-Pacific Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Nanotechnology In Cancer Treatment Market
8.3.4.1.1 Australia Nanotechnology In Cancer Treatment Market by Application
8.3.4.2 China Nanotechnology In Cancer Treatment Market
8.3.4.2.1 China Nanotechnology In Cancer Treatment Market by Application
8.3.4.3 India Nanotechnology In Cancer Treatment Market
8.3.4.3.1 India Nanotechnology In Cancer Treatment Market by Application
8.3.4.4 Japan Nanotechnology In Cancer Treatment Market
8.3.4.4.1 Japan Nanotechnology In Cancer Treatment Market by Application
8.3.4.5 South Korea Nanotechnology In Cancer Treatment Market
8.3.4.5.1 South Korea Nanotechnology In Cancer Treatment Market by Application
8.3.4.6 Rest of Asia-Pacific Nanotechnology In Cancer Treatment Market
8.3.4.6.1 Rest of Asia-Pacific Nanotechnology In Cancer Treatment Market by Application
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Nanotechnology In Cancer Treatment Market Overview
8.4.2 Middle East and Africa Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.4.3 Middle East and Africa Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.4.4 Middle East and Africa Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Nanotechnology In Cancer Treatment Market
8.4.4.1.1 South Africa Nanotechnology In Cancer Treatment Market by Application
8.4.4.2 Saudi Arabia Nanotechnology In Cancer Treatment Market
8.4.4.2.1 Saudi Arabia Nanotechnology In Cancer Treatment Market by Application
8.4.4.3 U.A.E Nanotechnology In Cancer Treatment Market
8.4.4.3.1 U.A.E Nanotechnology In Cancer Treatment Market by Application
8.4.4.4 Rest of Middle East and Africa Nanotechnology In Cancer Treatment Market
8.4.4.4.1 Rest of Middle East and Africa Nanotechnology In Cancer Treatment Market by Application
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Nanotechnology In Cancer Treatment Market Overview
8.5.2 South and Central America Nanotechnology In Cancer Treatment Market Forecasts and Analysis
8.5.3 South and Central America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Application
8.5.4 South and Central America Nanotechnology In Cancer Treatment Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Nanotechnology In Cancer Treatment Market
8.5.4.1.1 Brazil Nanotechnology In Cancer Treatment Market by Application
8.5.4.2 Argentina Nanotechnology In Cancer Treatment Market
8.5.4.2.1 Argentina Nanotechnology In Cancer Treatment Market by Application
8.5.4.3 Rest of South and Central America Nanotechnology In Cancer Treatment Market
8.5.4.3.1 Rest of South and Central America Nanotechnology In Cancer Treatment Market by Application
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NANOTECHNOLOGY IN CANCER TREATMENT MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NANOTECHNOLOGY IN CANCER TREATMENT MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. COMBIMATRIX CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GE HEALTHCARE
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LEADIANT BIOSCIENCES, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JOHNSON AND JOHNSON
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MALLINCKRODT PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND COMPANY INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NANOSPHERE INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CELGENE CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott Laboratories
2. Combimatrix Corporation
3. GE Healthcare
4. Leadiant Biosciences, Inc.
5. Johnson & Johnson
6. Mallinckrodt Plc
7. Merck & Company Inc.
8. Nanosphere Inc.
9. Pfizer, Inc.
10. Celgene Corporation
1. Abbott Laboratories
2. Combimatrix Corporation
3. GE Healthcare
4. Leadiant Biosciences, Inc.
5. Johnson & Johnson
6. Mallinckrodt Plc
7. Merck & Company Inc.
8. Nanosphere Inc.
9. Pfizer, Inc.
10. Celgene Corporation